{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:57:32Z","timestamp":1773655052213,"version":"3.50.1"},"reference-count":0,"publisher":"Australian Centre for Disease Control","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Commun Dis Intell (2018)"],"abstract":"<jats:p>The World Health Organization Western Pacific Region Gonococcal Antimicrobial Surveillance Programme examined over 11,000 isolates of\u00a0Neisseria gonorrhoeae\u00a0from 13 countries for resistance to antibiotics in 2003. Very high rates of resistance to penicillins and quinolones were again present in most centres, but little resistance to spectinomycin was detected. Several centres once more reported the presence of gonococci with decreased susceptibility to third generation cephalosporins. Treatment options for gonococcal disease acquired in the Region are increasingly limited.\u00a0Commun Dis Intell\u00a02005;29:62\u201364.<\/jats:p>","DOI":"10.33321\/cdi.2005.29.2","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:24:26Z","timestamp":1749601466000},"page":"62-64","source":"Crossref","is-referenced-by-count":1,"title":["Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003"],"prefix":"10.33321","volume":"29","author":[{"family":"WHO Western Pacific Gonococcal AMR Surveillance Programme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Tapsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18788","published-online":{"date-parts":[[2005,3,1]]},"container-title":["Communicable Diseases Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/download\/1867\/2912","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/download\/1867\/2912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:24:41Z","timestamp":1749601481000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/view\/1867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.33321\/cdi.2005.29.2","relation":{},"ISSN":["2209-6051"],"issn-type":[{"value":"2209-6051","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}